INSMED INC Revenue Other Manufactured Products (Deprecated 2018-01-31)
INSMED INC (INSM) reported Revenue Other Manufactured Products (Deprecated 2018-01-31) of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Income Statement › Other Income
us-gaap:RevenueOtherManufacturedProducts · last filed 2014-03-06
- INSMED INC revenue other manufactured products (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- INSMED INC revenue other manufactured products (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- INSMED INC revenue other manufactured products (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- INSMED INC revenue other manufactured products (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- INSMED INC revenue other manufactured products (deprecated 2018-01-31) for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- INSMED INC revenue other manufactured products (deprecated 2018-01-31) for fiscal 2011 was $3.42M, a 50.63% decline from fiscal 2010.
- INSMED INC revenue other manufactured products (deprecated 2018-01-31) for fiscal 2010 was $6.92M, a 24.82% decline from fiscal 2009.
- INSMED INC revenue other manufactured products (deprecated 2018-01-31) for fiscal 2009 was $9.20M.
| Period end | Revenue Other Manufactured Products (Deprecated 2018-01-31) 3 month | Revenue Other Manufactured Products (Deprecated 2018-01-31) 6 month | Revenue Other Manufactured Products (Deprecated 2018-01-31) 9 month | Revenue Other Manufactured Products (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $0.00 10-K · filed 2013-03-18 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-07 | $0.00 derived: sum of 2 quarters · filed 2012-11-07 | $0.00 10-Q · filed 2012-11-07 | $653.00K derived: sum of 4 quarters · filed 2014-03-06 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-07 | $0.00 10-Q · filed 2012-08-07 | $653.00K derived: sum of 3 quarters · filed 2014-03-06 | $1.09M derived: sum of 4 quarters · filed 2014-03-06 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-08 | $653.00K derived: sum of 2 quarters · filed 2014-03-06 | $1.09M derived: sum of 3 quarters · filed 2014-03-06 | $2.06M derived: sum of 4 quarters · filed 2014-03-06 |
| 2011-12-31 | $653.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $1.09M derived: sum of 2 quarters · filed 2014-03-06 | $2.06M derived: sum of 3 quarters · filed 2014-03-06 | $3.42M 10-K · filed 2014-03-06 |
| 2011-09-30 | $434.00K 10-Q · filed 2012-11-07 | $1.41M derived: sum of 2 quarters · filed 2012-11-07 | $2.76M 10-Q · filed 2012-11-07 | $4.08M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $977.00K 10-Q · filed 2012-08-07 | $2.33M 10-Q · filed 2012-08-07 | $3.65M derived: sum of 3 quarters · filed 2013-03-18 | $5.45M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $1.35M 10-Q · filed 2012-05-08 | $2.67M derived: sum of 2 quarters · filed 2013-03-18 | $4.48M derived: sum of 3 quarters · filed 2013-03-18 | $6.34M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $3.13M derived: sum of 2 quarters · filed 2013-03-18 | $4.99M derived: sum of 3 quarters · filed 2013-03-18 | $6.92M 10-K · filed 2013-03-18 |
| 2010-09-30 | $1.81M 10-Q · filed 2011-11-09 | $3.67M derived: sum of 2 quarters · filed 2011-11-09 | $5.60M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $1.86M 10-Q/A · filed 2011-08-08 | $3.79M 10-Q/A · filed 2011-08-08 | ||
| 2009-12-31 | $9.20M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |